PubRank

Arthur A M Wilde

Author PubWeight™ 317.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2009 4.99
2 Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012 4.63
3 Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2006 3.44
4 Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009 3.35
5 Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005 3.30
6 Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation 2009 3.11
7 Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007 2.88
8 Thoracoscopic video-assisted pulmonary vein antrum isolation, ganglionated plexus ablation, and periprocedural confirmation of ablation lesions: first results of a hybrid surgical-electrophysiological approach for atrial fibrillation. Circ Arrhythm Electrophysiol 2011 2.84
9 Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004 2.82
10 Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 2009 2.81
11 Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction. Circulation 2006 2.72
12 Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002 2.66
13 Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009 2.65
14 Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006 2.63
15 Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002 2.58
16 The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol 2010 2.56
17 Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J 2006 2.54
18 Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 2008 2.54
19 Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005 2.42
20 A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res 2008 2.39
21 Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol 2011 2.31
22 Genetic variation in SCN10A influences cardiac conduction. Nat Genet 2010 2.30
23 Unmasking of brugada syndrome by lithium. Circulation 2005 2.30
24 Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 2013 2.30
25 Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007 2.29
26 Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 2012 2.28
27 A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol 2005 2.21
28 Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol 2011 2.15
29 A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 2003 2.15
30 Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circ Res 2003 2.14
31 Inaccessibility to quinidine therapy is about to get worse. J Am Coll Cardiol 2013 2.12
32 Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria. J Cardiovasc Electrophysiol 2008 2.09
33 Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res 2005 2.06
34 Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment? J Am Coll Cardiol 2010 2.06
35 Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation 2011 2.04
36 Brugada syndrome. Circ Arrhythm Electrophysiol 2012 2.03
37 Con: Newborn screening to prevent sudden cardiac death? Heart Rhythm 2006 2.02
38 Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J 2007 1.98
39 Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 2012 1.96
40 The Brugada ECG pattern: a marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome. Circ Arrhythm Electrophysiol 2010 1.96
41 The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 2012 1.93
42 Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation 2014 1.93
43 Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 2009 1.92
44 Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children. A comprehensive, prospective, population-based study in the Netherlands. J Am Coll Cardiol 2011 1.92
45 Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome. Circ Cardiovasc Genet 2012 1.91
46 Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies. Heart Rhythm 2006 1.90
47 A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res 2003 1.89
48 A new ECG sign of proximal LAD occlusion. N Engl J Med 2008 1.89
49 Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol 2011 1.89
50 Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm 2010 1.85
51 A calcium sensor in the sodium channel modulates cardiac excitability. Nature 2002 1.83
52 Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 2003 1.82
53 Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol 2012 1.81
54 Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005 1.78
55 Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 2006 1.76
56 Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation. Heart Rhythm 2010 1.76
57 Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. Circulation 2007 1.74
58 Brugada phenocopy: new terminology and proposed classification. Ann Noninvasive Electrocardiol 2012 1.74
59 Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch. Heart Rhythm 2009 1.73
60 Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation. J Am Coll Cardiol 2010 1.71
61 The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol 2009 1.70
62 Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med 2008 1.68
63 The diagnostic and therapeutic aspects of loss-of-function cardiac sodium channelopathies in children. Heart Rhythm 2012 1.66
64 Value of history-taking in syncope patients: in whom to suspect long QT syndrome? Europace 2009 1.65
65 SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet 2009 1.64
66 Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006 1.63
67 Recurrent intrauterine fetal loss due to near absence of HERG: clinical and functional characterization of a homozygous nonsense HERG Q1070X mutation. Heart Rhythm 2008 1.62
68 Delay in right ventricular activation contributes to Brugada syndrome. Circulation 2004 1.61
69 The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation 2007 1.58
70 Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family. Heart Rhythm 2006 1.57
71 Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm 2008 1.56
72 A family with Andersen-Tawil syndrome and dilated cardiomyopathy. Heart Rhythm 2006 1.56
73 Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: results from a multicenter study. Circ Cardiovasc Genet 2009 1.54
74 Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm 2011 1.54
75 In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models. J Am Coll Cardiol 2012 1.53
76 Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 2012 1.53
77 Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail 2012 1.51
78 Microvolt T-wave alternans during exercise and pacing are not comparable. Europace 2009 1.49
79 Genetic control of sodium channel function. Cardiovasc Res 2003 1.48
80 A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet 2011 1.48
81 Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome. Heart Rhythm 2012 1.47
82 Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome. Heart Rhythm 2013 1.46
83 Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome. Europace 2011 1.46
84 Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm 2011 1.46
85 T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol 2014 1.45
86 The site of origin of torsade de pointes. Heart 2011 1.45
87 Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications. Circulation 2006 1.42
88 Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation? Heart Rhythm 2005 1.42
89 Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur Heart J 2011 1.41
90 Mild-to-moderate kidney dysfunction and the risk of sudden cardiac death in the setting of acute myocardial infarction. Heart Rhythm 2011 1.40
91 Clinical and genetic characterization of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy caused by a plakophilin-2 splice mutation. Cardiology 2012 1.40
92 Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet 2011 1.38
93 Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010 1.38
94 High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Am Heart J 2007 1.38
95 Accurate electrocardiographic assessment of the QT interval: teach the tangent. Heart Rhythm 2008 1.37
96 Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. Heart Rhythm 2010 1.36
97 Haplotype-sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation. Am J Hum Genet 2009 1.31
98 Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain 2009 1.27
99 Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study. Circ Arrhythm Electrophysiol 2008 1.23
100 Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 2013 1.22
101 In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol 2006 1.19
102 Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome. J Clin Invest 2008 1.18
103 Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med 2009 1.18
104 Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann Intern Med 2008 1.17
105 Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J 2012 1.17
106 Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol 2012 1.15
107 Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. Europace 2011 1.14
108 Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancer. J Urol 2010 1.13
109 Exclusion of multiple candidate genes and large genomic rearrangements in SCN5A in a Dutch Brugada syndrome cohort. Heart Rhythm 2007 1.13
110 Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. Europace 2010 1.12
111 Genetic and clinical advances in congenital long QT syndrome. Circ J 2014 1.12
112 The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Circ Arrhythm Electrophysiol 2012 1.11
113 Cardiac ion channels in health and disease. Heart Rhythm 2009 1.11
114 Somatic mosaicism contributes to phenotypic variation in Timothy syndrome. Am J Med Genet A 2011 1.09
115 Relation between basic and clinical electrophysiologic characteristics in Brugada syndrome: facts or fiction? J Cardiovasc Electrophysiol 2003 1.09
116 The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why? J Cardiovasc Electrophysiol 2008 1.07
117 Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: impact of new task force criteria. Circ Arrhythm Electrophysiol 2010 1.07
118 Diagnostic performance of various QTc interval formulas in a large family with long QT syndrome type 3: Bazett's formula not so bad after all... Ann Noninvasive Electrocardiol 2003 1.07
119 Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. Heart Rhythm 2008 1.07
120 Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator. J Am Coll Cardiol 2016 1.06
121 Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy. Circ Res 2009 1.06
122 Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2012 1.06
123 Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience. Eur J Heart Fail 2013 1.05
124 Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives. Circ Arrhythm Electrophysiol 2012 1.05
125 Sudden death in the young: what do we know about it and how to prevent? Circ Arrhythm Electrophysiol 2010 1.04
126 Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes. PLoS One 2013 1.04
127 Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome. Cardiovasc Res 2005 1.03
128 Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience. Circulation 2013 1.02
129 Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy. J Am Coll Cardiol 2012 1.01
130 A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22. J Cardiovasc Electrophysiol 2007 1.01
131 New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol 2009 1.00
132 Long QT syndrome: beyond the causal mutation. J Physiol 2013 1.00
133 Prevalence and characterization of ECG abnormalities after intracerebral hemorrhage. Neurocrit Care 2010 1.00
134 Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A 2009 1.00
135 An intronic mutation leading to incomplete skipping of exon-2 in KCNQ1 rescues hearing in Jervell and Lange-Nielsen syndrome. Prog Biophys Mol Biol 2008 0.99
136 Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. Am J Med Genet A 2008 0.98
137 High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the Fainting Assessment study. J Cardiovasc Electrophysiol 2007 0.98
138 Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks? Circ Arrhythm Electrophysiol 2011 0.96
139 SCN5A overlap syndromes: no end to disease complexity? Europace 2008 0.96
140 How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010 0.96
141 Predictive genetic testing for cardiovascular diseases: impact on carrier children. Am J Med Genet A 2008 0.96
142 Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol 2014 0.95
143 Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score. Europace 2013 0.95
144 Voltage-gated sodium channels: action players with many faces. Ann Med 2006 0.95
145 Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. Heart Rhythm 2008 0.95
146 Exercise-induced ECG changes in Brugada syndrome. Circ Arrhythm Electrophysiol 2009 0.94
147 Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside. Heart 2013 0.93
148 Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction. Eur J Heart Fail 2011 0.92
149 Quantitative trait loci for electrocardiographic parameters and arrhythmia in the mouse. J Mol Cell Cardiol 2010 0.92
150 Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. Circ Res 2013 0.91
151 A connexin40 mutation associated with a malignant variant of progressive familial heart block type I. Circ Arrhythm Electrophysiol 2012 0.91
152 Contribution of inherited heart disease to sudden cardiac death in childhood. Pediatrics 2007 0.91
153 Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006 0.91
154 Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development. Circ Arrhythm Electrophysiol 2008 0.90
155 Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients. Sci Transl Med 2011 0.90
156 HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency. Cardiovasc Res 2005 0.90
157 Navigating the mini-maze: systematic review of the first results and progress of minimally-invasive surgery in the treatment of atrial fibrillation. Int J Cardiol 2011 0.90
158 Na+ channel mutation leading to loss of function and non-progressive cardiac conduction defects. J Mol Cell Cardiol 2003 0.89
159 Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. Eur Heart J 2011 0.89
160 IKs in heart and hearing, the ear can do with less than the heart. Circ Cardiovasc Genet 2013 0.89
161 Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation. Cardiovasc Res 2007 0.88
162 Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective. Am J Med Genet A 2009 0.88
163 Ventricular dysfunction in a family with long QT syndrome type 3. Europace 2013 0.87
164 Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J 2007 0.87
165 The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy. Eur J Hum Genet 2012 0.87
166 Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail 2012 0.87
167 Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias. Europace 2005 0.86
168 Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers. Eur J Hum Genet 2009 0.86
169 Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers. Am J Cardiol 2013 0.86
170 Long QT syndrome: a double hit hurts more. Heart Rhythm 2010 0.86
171 Diurnal variation of ventricular repolarization in a large family with LQT3-Brugada syndrome characterized by nocturnal sudden death. Heart Rhythm 2006 0.86
172 Dual inheritance of sudden death from cardiovascular causes. N Engl J Med 2008 0.85
173 Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide. Neth Heart J 2015 0.85
174 Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome. J Cardiovasc Electrophysiol 2009 0.85
175 Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics. Europace 2013 0.85
176 Mechanisms of inherited cardiac conduction disease. Europace 2005 0.85
177 SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility. PLoS One 2012 0.85
178 Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade. Cardiovasc Res 2002 0.85
179 The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening. Eur Heart J 2009 0.84
180 Exercise related syncope, when it's not the heart. Clin Auton Res 2004 0.84
181 Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview. Expert Opin Pharmacother 2008 0.83
182 The complexity of genotype-phenotype relations associated with loss-of-function sodium channel mutations and the role of in silico studies. Am J Physiol Heart Circ Physiol 2008 0.83
183 A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics. Cardiovasc Res 2003 0.83
184 SNPs identified as modulators of ECG traits in the general population do not markedly affect ECG traits during acute myocardial infarction nor ventricular fibrillation risk in this condition. PLoS One 2013 0.83
185 Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood. J Am Coll Cardiol 2005 0.82
186 Loss-of-function sodium channel mutations in infancy: a pattern unfolds. Circulation 2011 0.82
187 Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries. J Am Coll Cardiol 2013 0.82
188 The chemical compound PTC124 does not affect cellular electrophysiology of cardiac ventricular myocytes. Cardiovasc Drugs Ther 2012 0.82
189 Genetic aspects of vasovagal syncope: a systematic review of current evidence. Europace 2009 0.81
190 The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome. Pediatr Cardiol 2009 0.81
191 Electrocardiographic P wave changes after thoracoscopic pulmonary vein isolation for atrial fibrillation. J Interv Card Electrophysiol 2013 0.81
192 Brugada Syndrome and the Subcutaneous Implantable Cardioverter-Defibrillator. J Am Coll Cardiol 2016 0.81
193 IK1 modulates the U-wave: insights in a 100-year-old enigma. Heart Rhythm 2008 0.80
194 The molecular genetics of arrhythmias. Cardiovasc Res 2005 0.80
195 Late sodium current inhibition in acquired and inherited ventricular (dys)function and arrhythmias. Cardiovasc Drugs Ther 2013 0.80
196 A complex double deletion in LMNA underlies progressive cardiac conduction disease, atrial arrhythmias, and sudden death. Circ Cardiovasc Genet 2011 0.80
197 TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy. J Cell Biochem 2012 0.80
198 Mortality risk of untreated myosin-binding protein C-related hypertrophic cardiomyopathy: insight into the natural history. J Am Coll Cardiol 2011 0.80
199 Substitution of a conserved alanine in the domain IIIS4-S5 linker of the cardiac sodium channel causes long QT syndrome. Cardiovasc Res 2005 0.79
200 Do J waves constitute a syndrome? J Electrocardiol 2013 0.79
201 Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy. Heart Rhythm 2009 0.79
202 A novel autosomal dominant condition consisting of congenital heart defects and low atrial rhythm maps to chromosome 9q. Eur J Hum Genet 2011 0.79
203 Arrhythmias in Brugada syndrome: changing throughout day and season? Heart Rhythm 2008 0.79
204 Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery. Heart Rhythm 2007 0.79
205 Sodium channelopathies: do we really understand what's going on? J Cardiovasc Electrophysiol 2010 0.79
206 Cost-effectiveness of genotyping in inherited arrhythmia syndromes: are we getting value for the money? Circ Arrhythm Electrophysiol 2009 0.78
207 The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. Heart Rhythm 2012 0.78
208 Clinical and genetic analysis of long QT syndrome in children from six families in Saudi Arabia: are they different? Pediatr Cardiol 2009 0.78
209 Genetic testing in cardiovascular diseases. Curr Opin Cardiol 2010 0.78
210 Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era. Am Heart J 2009 0.78
211 Mortality of inherited arrhythmia syndromes: insight into their natural history. Circ Cardiovasc Genet 2012 0.78
212 Clinical utility gene card for: long-QT syndrome (types 1-13). Eur J Hum Genet 2013 0.78
213 ECG quantification of myocardial scar does not differ between primary and secondary prevention ICD recipients with ischemic heart disease. Pacing Clin Electrophysiol 2009 0.77
214 Exercise extreme caution when calling rare genetic variants novel arrhythmia syndrome susceptibility mutations. Heart Rhythm 2010 0.77
215 A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding. Biochim Biophys Acta 2012 0.77
216 Syncope during exercise, documented with continuous blood pressure monitoring during ergometer testing. Clin Auton Res 2005 0.77
217 Images in cardiovascular medicine. Prominent crypt formation in the inferoseptum of a hypertrophic cardiomyopathy mutation carrier mimics noncompaction cardiomyopathy. Circulation 2007 0.77
218 The relationship between pre-participation screening of young competitive athletes and family screening. J Am Coll Cardiol 2009 0.77
219 Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location. J Cardiovasc Electrophysiol 2013 0.77
220 The "accordion sign," a new tune in arrhythmogenic right ventricular dysplasia/cardiomyopathy magnetic resonance imaging? J Am Coll Cardiol 2009 0.77
221 Scar tissue and microvolt T-wave alternans. Int J Cardiovasc Imaging 2014 0.77
222 Do patients with long QT syndrome remain at risk for sudden cardiac death after 40 years of age? Nat Clin Pract Cardiovasc Med 2008 0.77
223 Cardiac involvement in Dutch patients with sarcoglycanopathy: a cross-sectional cohort and follow-up study. Muscle Nerve 2014 0.77
224 Vasovagal syncope or ventricular fibrillation. Your diagnosis better be accurate. Clin Auton Res 2007 0.77
225 Activated human platelet products induce proarrhythmic effects in ventricular myocytes. J Mol Cell Cardiol 2011 0.77
226 "J-wave syndromes" bring the ATP-sensitive potassium channel back in the spotlight. Heart Rhythm 2012 0.77
227 Implantable cardioverter defibrillator as a bridge to recovery in an infant with cardiac rhabdomyoma. Eur J Pediatr 2008 0.77
228 Brugada syndrome: in search of a genotype-phenotype relationship. Herzschrittmacherther Elektrophysiol 2002 0.76
229 GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability. Am J Hum Genet 2016 0.76
230 The patient with hypertrophic cardiomyopathy has a family. Heart 2011 0.76
231 Spontaneous electrocardiographic fluctuations in Brugada syndrome: does it matter? Eur Heart J 2006 0.75
232 Brugada syndrome and the use of anesthetics. Heart Rhythm 2006 0.75
233 Bringing home the bacon? The next step in cardiac sodium channelopathies. J Clin Invest 2014 0.75
234 Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel. J Cardiovasc Transl Res 2015 0.75
235 Dilation of the Aorta Ascendens Forms Part of the Clinical Spectrum of HCN4 Mutations. J Am Coll Cardiol 2016 0.75
236 Genetic Basis of Ventricular Arrhythmias. Curr Cardiovasc Risk Rep 2010 0.75
237 Desmosomal mutations across the fence. Heart Rhythm 2011 0.75
238 The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy. Am J Cardiol 2011 0.75
239 QT prolongation and mortality in hospital settings: identifying patients at high risk. Mayo Clin Proc 2013 0.75
240 Understanding torsade de pointes: a bridge to tailored drug therapy? Cardiovasc Drugs Ther 2002 0.75
241 Non-compaction: a distinct cardiomyopathy or non-specific morphological trait? Eur Heart J 2008 0.75
242 Clinical assessment of the pathogenicity of unknown variants in long-QT syndrome: does the pendulum swing back? J Cardiovasc Electrophysiol 2012 0.75
243 Treatment for patients with catecholaminergic polymorphic ventricular tachycardia: are we in need of randomized trials? J Electrocardiol 2012 0.75
244 Catecholaminergic polymorphic ventricular tachycardia: important messages from case reports. Europace 2010 0.75
245 Unidentified candidates for cardiac resynchronization therapy: guideline adherence in a large academic outpatient clinic in the Netherlands. Pacing Clin Electrophysiol 2012 0.75
246 To Add or Not to Add Mitral Valve Surgery to Septal Myectomy in HOCM Patients. J Am Coll Cardiol 2017 0.75
247 [Premature sudden death--consider serious familial heart rhythm disturbances]. Ned Tijdschr Geneeskd 2011 0.75
248 Syncope and exercise-related ventricular tachycardia. Ann Noninvasive Electrocardiol 2012 0.75
249 Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. Int J Cardiol 2012 0.75
250 Documented atrial fibrillation recurrences after pulmonary vein isolation are associated with diminished quality of life. J Cardiovasc Med (Hagerstown) 2016 0.75
251 [Catecholaminergic polymorphic ventricular tachycardia; possible diagnosis in cases of syncope and sudden death of family members]. Ned Tijdschr Geneeskd 2015 0.75
252 Value of serial heart rate variability measurement for prediction of appropriate ICD discharge in patients with heart failure. J Cardiovasc Electrophysiol 2013 0.75
253 Complex inheritance for susceptibility to sudden cardiac death. Curr Pharm Des 2013 0.75
254 [Thoracoscopic treatment of atrial fibrillation]. Ned Tijdschr Geneeskd 2012 0.75
255 Genetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart. Future Cardiol 2010 0.75